Bajaj Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
320.05
1.4 (0.44%)
BSENSE

Nov 20

BSE+NSE Vol: 56.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 18.92% vs 11.14% in Sep 2025

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Sep 2026 is 26.82% vs 17.44% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 15.85% vs 9.82% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 7.55% vs -29.44% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025

Compare Quarterly Results Of Bajaj Healthcare With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
175.90
113.48
62.42
55.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
175.90
113.48
62.42
55.01%
Raw Material Cost
98.41
44.26
54.15
122.35%
Purchase of Finished goods
0.00
7.72
-7.72
-100.00%
(Increase) / Decrease In Stocks
-7.04
0.10
-7.14
-7,140.00%
Employee Cost
19.11
25.16
-6.05
-24.05%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
34.21
19.17
15.04
78.46%
Total Expenditure (Excl Depreciation)
144.69
96.41
48.28
50.08%
Operating Profit (PBDIT) excl Other Income
31.21
17.07
14.14
82.84%
Other Income
0.89
0.22
0.67
304.55%
Operating Profit (PBDIT)
32.10
17.29
14.81
85.66%
Interest
5.98
3.16
2.82
89.24%
Exceptional Items
-0.29
0.00
-0.29
Gross Profit (PBDT)
26.12
14.13
11.99
84.85%
Depreciation
7.65
3.62
4.03
111.33%
Profit Before Tax
18.48
10.51
7.97
75.83%
Tax
4.10
1.54
2.56
166.23%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.38
8.98
5.40
60.13%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
-0.29
0.00
-0.29
Net Profit
14.09
8.98
5.11
56.90%
Equity Capital
16.83
38.21
-21.38
-55.95%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.19
0.24
3.95
1,645.83%
Diluted Earnings per share
4.18
0.23
3.95
1,717.39%
Operating Profit Margin (Excl OI)
17.74%
15.04%
0.00
2.70%
Gross Profit Margin
14.85%
12.45%
0.00
2.40%
PAT Margin
8.18%
7.91%
0.00
0.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 175.90 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 6.20% vs 8.21% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 18.92% vs 11.14% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 14.09 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 2.85% vs 159.96% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 26.82% vs 17.44% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.21 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 8.56% vs 26.76% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 15.85% vs 9.82% in Sep 2025

Quarterly - Interest
Interest 5.98 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -1.81% vs 9.34% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 7.55% vs -29.44% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.74%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025